VIVO ASIA OPPORTUNITY FUND, L.P.
Profile
Company Names
VIVO ASIA OPPORTUNITY FUND, L.P.
VIVO OPPORTUNITY CAYMAN FUND, L.P.
Addresses
192 LYTTON AVENUE, PALO ALTO, CA 94301
Phone Numbers
(650) 688-0818
Entity Type:
LIMITED PARTNERSHIP
Industry:
PRIVATE EQUITY FUND
Year Incorporated:
2021
State Incorporated:
CAYMAN ISLANDS
Total Amount Raised:
$148,500,000.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2021-08-26
$148,500,000.00
INDEFINITE
INDEFINITE
People
First Name
Middle Name
Last Name
Titles
Related Companies
GAURAV
AGGARWAL
DIRECTOR
HYPERION THERAPEUTICS INC
| NEXTWAVE PHARMACEUTICALS INC
| AUSPEX PHARMACEUTICALS, INC.
| VIVO OPPORTUNITY FUND, L.P.
| VIVO OPPORTUNITY CO-INVEST, L.P.
| VIVO OPPORTUNITY CO-INVEST (W), L.P.
| UNICYCIVE THERAPEUTICS, INC.
| VIVO OPPORTUNITY CAYMAN FUND, L.P.
| VIVO CAPITAL FUND X, L.P.
| BONUM THERAPEUTICS, INC.
SHAN
FU
DIRECTOR
FRANK
KUNG
DIRECTOR
SAGENT HOLDING CO.
| REVANCE THERAPEUTICS, INC.
| NEXTWAVE PHARMACEUTICALS INC
| VIVO VENTURES VII AFFILIATES FUND, L.P.
| VIVO CAPITAL FUND VIII, L.P.
| VIVO CAPITAL SURPLUS FUND VIII, L.P.
| AMYRIS, INC.
| VIVO OPPORTUNITY FUND, L.P.
| VIVO CAPITAL FUND IX, L.P.
| VIVO OPPORTUNITY CO-INVEST, L.P.
| VIVO OPPORTUNITY CO-INVEST (W), L.P.
| VIVO INNOVATION FUND II, L.P.
| VIVO ASIA OPPORTUNITY FUND, L.P.
| VIVO OPPORTUNITY CAYMAN FUND, L.P.
| VIVO CAPITAL FUND X, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
